Portfolio company
DeepScan Diagnostics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops cell-free DNA blood tests for veterinarians to detect cancer and monitor treatment response in dogs.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
FidoCure
The company provides genomic testing and AI-enabled personalised treatment recommendations for dogs with cancer to veterinarians and pet owners.
PETDX
This company develops liquid biopsy blood tests for the early detection of cancer in dogs for use by veterinary professionals.
LEAH Labs
This company develops gene-edited cell therapies for dogs with cancer for use by veterinarians.
Ellie Diagnostics
This company provides laboratory testing services and wellness reports to veterinary clinics and pet owners.
SpotItEarly
The company develops an artificial intelligence and canine-based breath test for early cancer screening in individuals and high-risk groups.
MI:RNA
This company develops microRNA and artificial intelligence based diagnostic tests to detect diseases in companion and production animals for the veterinary and agricultural sectors.
ScoutBio
The company develops monoclonal antibodies and gene therapies for pets to treat chronic diseases.
DIG Labs
This company develops image-based artificial intelligence software for real-time pet health screenings and diagnostic insights for pet owners and animal care brands.